You are here: Industry Insights > Chinese market

News List

The Layout of Inhalation Formulations in the Chinese Market (I) PharmaSources/zhulikou431
June 24, 2020
Inhalation formulations are a dosage form with high technical barriers, with relatively few pharmaceutical enterprises entering this field at the beginning.
The Layout of Inhalation Formulations in the Chinese Market (II) PharmaSources/Zhulikou431
June 24, 2020
As the inhalation formulation market is developing in China, the Chinese government has gradually introduced favorable policies to offer support.
AstraZeneca:2018 Sale Directions from 2017 Financial Report and Chinese Market Shulin Yang
February 12, 2018
Global pharmaceutical enterprises have successively published their 2017 financial reports recently, and there were good and poor results
Which is to dominate the future heart failure drug market?(2) en-cphi.cn
October 27, 2017
Sales of Entresto® rising steadily upon the Class I recommendation by the European and American heart failure guideline...
In-depth report on antihypertensive drugs: “Silent killer” gives rise to a huge market (3) en-cphi.cn
October 24, 2017
Calcium channel blockers, angiotensin II receptor blockers (ARBs) and compound preparations accounted for more than half of the market shares among the antihypertensive drugs in China in 2015, separately accounting for 35%, 26% and 16%.
In-depth report on antihypertensive drugs: “Silent killer” gives rise to a huge market (2) en-cphi.cn
October 23, 2017
From the perspective of the international market, the antihypertensive drug market peaked at USD 54.9 billion in 2010, and the market size has declined year by year...
Sartorius Stedim Biotech opens a New validation service laboratory at its Shanghai site cphi-online
January 16, 2017
Comprehensive validation services for the Chinese market.